BioCentury
ARTICLE | Company News

BioPhausia, Medivir deal

June 20, 2011 7:00 AM UTC

Medivir completed its previously announced subsequent tender offer to acquire specialty pharma BioPhausia in a cash and stock deal. As of June 14, 322.2 million shares (94%) have been tendered. Medivi...